Clinical trial on trial on eraippu erumal with yoga therapy

An open labelled non randomised phase II comparitive clinical trial to evaluate the therapeutic efficacy of SIDDHAR YOGAM THERAPY and KHARUN THULASI KARPAM (SIDDHA KALPA MEDICINE INTERNAL) for ERAIPPU ERUMAL (BRONCHIAL ASTHMA)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019754

Enrollment

Registered

2019-06-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J709- Respiratory conditions due to unspecified external agent

Interventions

Intervention1: SIDDHAR YOGAM THERAPY WITH SIDDHA KALPA MEDICINE KHARUN THULASI KARPAM: SIDDAR YOGAM THERAPY for 48 days With KHARUN THULASI KARPAM DOSE 1-2Gms od DURATION-48 Days Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: Patient with the symptoms of Nasal congestion Rhinorrhea Tightness of chest Recurrent attacks of dyspnoea Cough with expectoration Wheezing added sound (Rhonchi) H/O allergy, sneezing. Patients who are willing to take radiological investigation and provide blood for lab investigation.

Exclusion criteria

Exclusion criteria: Patient with Age group less than 15 and above 65 years Systemic Hypertension Cardiac disease Renal disease Tuberculosis Chronic Bronchitis Status Asthmaticus Auto immune disease

Design outcomes

Primary

Measure	Time frame
Before and after treatment measurements of HR/PR/RR/BP will give the efficacy data Hopefully helps to know about the comparative therapeutic efficacy dataTimepoint: Group I - Intermittent siddhar yogam therapy within 48 days Ist sitting 50 percentage of symptoms will reduce IInd sittind 80 percentage of symptoms will reduce Group II after giving internal medicine for 48 days 40 percentage of symptoms will reduce After giving both internal and external yoga therapy for 48 days 80 percentage of symptoms will reduce	—

Measure

Time frame

Before and after treatment measurements of HR/PR/RR/BP will give the efficacy data Hopefully helps to know about the comparative therapeutic efficacy dataTimepoint: Group I - Intermittent siddhar yogam therapy within 48 days Ist sitting 50 percentage of symptoms will reduce IInd sittind 80 percentage of symptoms will reduce Group II after giving internal medicine for 48 days 40 percentage of symptoms will reduce After giving both internal and external yoga therapy for 48 days 80 percentage of symptoms will reduce

—

Secondary

Measure	Time frame
Before and after treatment measurements of HR/PR/RR/BP will give the efficacy data Hopefully helps to know about the comparative therapeutic efficacy dataTimepoint: Group I - Intermittent siddhar yogam therapy within 48 days Ist sitting 50 percentage of symptoms will reduce IInd sittind 80 percentage of symptoms will reduce Group II after giving internal medicine for 48 days 40 percentage of symptoms will reduce After giving both internal and external yoga therapy for 48 days 80 percentage of symptoms will reduce	—

Measure

Time frame

—

Countries

India

Contacts

Public ContactS MUTHU VIGNESH

Govt Siddha Medical College Hospital

arunapriya1995@gmail.com9865105356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026